The incredible Jeff Aronin is currently chairman and CEO of the phenomenal and creative healthcare development and biopharmaceutical investment firm, “Paragon Biosciences”. Over the years, Aronin has consistently developed his proficiency as a chief executive officer, developing a multitude of skills related to, but not limited to: business development, finance and brand marketing and in addition, an increasing amount of leadership skills. He totally understands the details of managing the day-to-day operations of a global corporation and with his background, Paragon Biosciences can be sure that it is in great hands.
It is a business development firm, of new and small biotechnology companies, which supports healthcare companies throughout its early growth stages and provides proper investments to allow the companies to survive during the difficult struggles faced during the early stages of development. Paragon Biosciences is dedicated firm in providing innovative solutions for helping people to live healthier and longer lives (http://reporterexpert.com/jeff-aronin-paragonbiosci/).
Through Paragon Biosciences development stages, the patients’ needs are the motivation. The science of which creates subjected diseases must be taken into complete consideration, studied diligently and the complete essence of such diseases must be revealed. Paragon Biosciences companies are built specifically for developing medicines that can capitalize on the various diseases that currently do not have any treatments discovered. There are currently over 6,000 diseases that aren’t treatable and with the Paragon Biosciences company in place, that number is to eventually decrease to zero.
Companies it which Paragon Biosciences have developed are the following:
* Castle Creek Pharma – which specializes in developing therapeutic solutions for patients with various dermatologist conditions.
* Precision BP – which specializes in developing treatments for various genetic oncology diseases.
* Harmony Biosciences – specializes in developing treatments for patients with sleep and central nervous system disorders.
* Decade Pharmaceuticals – specializes in therapeutic solutions for improving the quality of life of patients.
Prior to becoming chairman and CEO of Paragon Biosciences. In 2000, Aronin the was founder, president, and CEO of the biopharmaceutical company, “Ovation Pharmaceuticals, Inc.”. He would achieve miraculous experiences with the company and gain a greater level of proficiency within the biosciences world. But later, in 2009, Lundbeck, Inc. would acquire Paragon Biosciences, as Aronin had other plans. In 2010, Jeff Aronin starts his journey with Paragon Biosciences.
For more information on Jeffery Aronin or Paragon Biosciences, please visit https://www.jeffaronin.com/ for further details.